Inflammasome Therapeutics, Inc. — Form D
Inflammasome Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-14. The offering totals $3.8M, of which $2.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-08-14
- Form: D
- Accession: 0001989925-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.8M
- Amount sold: $2.8M
- Remaining: $1.0M
- Investors: 24
- Date of first sale: 2023-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489685
Issuer
- Name: Inflammasome Therapeutics, Inc.
- CIK: 0001989925
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 57 CHAPEL ST. STE. 100, NEWTON, MA, 02458
- Phone: 6173311071
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Joon Lee | Director | LA JOLLA, CA |
| Balamurali Ambati | Director | Newton, MA |
| Napoleone Ferrara | Director | NEWTON, MA |
| Napoleone Ferrara | Related Person | NEWTON, MA |
| Paul Ashton | Director | Newton, MA |
| Paul Ashton | Executive Officer | Newton, MA |
| Jayakrishna Ambati | Director | NEWTON, MA |
| Jayakrishna Ambati | Related Person | NEWTON, MA |
| Mary Weber | Director | Newton, MA |
| Balamurali K. Ambati | Related Person | NEWTON, MA |
| Chaniyilparampu N. Ramchand | Related Person | NEWTON, MA |
| Babur B. Lateef | Related Person | NEWTON, MA |
Other filings by this issuer (3)
More